White Papers
Optimizing Excipients for Biologic Therapies Delivered via Inhalation
The shift toward biologics delivered via the respiratory route is accelerating—and with it comes the need for precision in excipient selection. Whether in nebulized liquids or dry powder inhalers, biologics demand tailored formulation strategies to ensure safety, stability, and therapeutic effectiveness.
Accelerate Commercial Tech Transfers for Oral Solid Dosage (OSD) Success
Efficient tech transfer is critical to the success of every Oral Solid Dosage (OSD) product—especially when transitioning from development to full-scale commercial manufacturing.
Automating Octet® Assays for Ligand Screening
Drug development and production is challenging. Avitide, based in Lebanon, New Hampshire, provides on-demand development and supply of high-performance affinity purification resins for the manufacture of biotherapeutic drug molecules.
Unlock New Frontiers in ALS Research with iPSC-Derived Motor Neurons and Microglia
A Cutting-Edge Model for Neurodegenerative Disease Studies
Ensure Compliance & Integrity: Key Considerations for Labeling Your Cell or Gene Therapy
As cell and gene therapies continue to revolutionize healthcare, ensuring proper labeling is critical for maintaining product integrity, regulatory compliance, and successful clinical trial execution.
Breaking Boundaries in Drug Discovery: The Rise of Targeted Protein Degraders
Targeted protein degraders like PROTACs, LYTACs, AUTACs, and DACs are redefining modern therapeutics. These tools eliminate disease-causing proteins, even those once considered “undruggable”.They offer new hope for treating cancer, inflammation, and neurodegenerative disorders.
Achieve Precise & Reliable Weighing Results – Every Time!
Discover expert insights on minimizing errors, optimizing balance placement, and ensuring high-precision weighing in your lab.
Pluripotent Stem Cells and Their Critical Role in Developing Organoids
In recent years, biomedical research has transcended the limitations of 2D cell culture, paving the way for advanced models that deepen our understanding of developmental biology, disease mechanisms, and the development of more effective tissue-replacement therapies.
"Characterizing Drug Substance Properties Early: Optimize Your Drug Product Formulation"
Learn how early characterization of drug substances can lead to more effective formulations and avoid costly delays.
"Manufacturing Process Scale-Up for Phase III: Clear Sailing or Storms Ahead?"
Gain valuable insights into scaling up your manufacturing process for Phase III clinical trials. Learn how to avoid common pitfalls and ensure a seamless transition from small-scale to commercial production.
